Loading insider details...
Beta
Latest Form 4 (Jul 17, 2026): Disposition to Issuer of 3,773 CPRX shares, $118.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 17, 2026 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Disposition to Issuer | 3,773 | $118.8K |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | Disposition to Issuer | 6,692 | n/a |
| Dec 10, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 1,413 | n/a |
| Nov 25, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 947 | n/a |
| Jun 12, 2025 | Avidity Biosciences, Inc. (RNA) | Grant/Award | 6,692 | n/a |
| Dec 11, 2024 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 1,413 | n/a |
| Nov 25, 2024 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Grant/Award | 23,248 | n/a |
| Oct 9, 2024 | Avidity Biosciences, Inc. (RNA) | Exercise/Conversion | 30,000 | $828.9K |
| Jun 14, 2024 | Avidity Biosciences, Inc. (RNA) | Grant/Award | 13,489 | n/a |
| Dec 12, 2023 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Grant/Award | 29,524 | n/a |